The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior

Cell Cycle

Volumn 8, Issue 19, 2009, Pages 3120-3124

  Liu, Yan ^a   Elf, Shannon E ^a   Asai, Takashi ^a   Miyata, Yasuhiko ^a   Liu, Yuhui ^a   Sashida, Goro ^a   Huang, Gang ^a   Di Giandomenico, Silvana ^a   Koff, Andrew ^a   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aging; Apoptosis; Gfi 1; Hematopoietic stem cell; Leukemia stem cell; Necdin; p21; p53; Quiescence; Self renewal; Slug

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2C; NECDIN; PROTEIN MDM2; PROTEIN P53; PUMA PROTEIN; RIBOSOME PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR SLUG; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; BIOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL FUNCTION; CELL GROWTH; CELL RENEWAL; CELL STRAIN 3T3; CELL STRESS; CELL TRANSFORMATION; DNA DAMAGE; GENE EXPRESSION; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; MYELODYSPLASTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; REVIEW; SENESCENCE; TARGETED GENE REPAIR; UPREGULATION;

EID: 70349897697     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.19.9627     Document Type: Review

References (73)

1. Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, Weissman IL. Differential expression of novel potential regulators in hematopoietic stem cells. PloS Genet 2005; 1:32-35
2. Attar EC, Scadden DT. Regulation of hematopoietic stem cell growth. Leukemia 2004; 18:1760-1768 (Pubitemid 39530003)
3. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003; 21:759-786 (Pubitemid 37174547)
4. Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005; 202:1599-1611 (Pubitemid 41746605)
5. Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6:909-923 (Pubitemid 44862676)
6. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-412 (Pubitemid 351574202)
7. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008; 9:702-712
8. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84:2391-2411 (Pubitemid 24317369)
9. Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 2002; 21:3475-3495 (Pubitemid 34587717)
10. Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, et al. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 2006; 9:175-187 (Pubitemid 43357944)
11. Wilson A, Trumpp A. Bone-marrow haematopoieticstem- cell niches. Nat Rev Immunol 2006; 6:93-106.
12. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-315
13. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10:789-799 (Pubitemid 39070849)
14. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441:475-482 (Pubitemid 44050144)
15. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006; 441:518-522 (Pubitemid 44050154)
16. Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM, et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med 2008; 205:1395-1408 (Pubitemid 351831495)
17. Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008; 453:1072-1078 (Pubitemid 351871736)
18. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, et al. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008; 3:416-428
19. Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, et al. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene 2007; 26:4032-4037 (Pubitemid 46884297)
20. Sashida G, Liu Y, Elf S, Miyata Y, Ohyashiki K, Izumi M, et al. ELF4/MEF activates MDM2 expression and blocks onocogene-induced p16 activation to promote transformation. Mol Cell Biol 2009; 29:3687-3699
21. Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 4:37-48.
22. TeKippe M, Harrison DE, Chen J. Expansion of hematopoietic stem cell phenotype and activity in Trp53- null mice. Exp Hematol 2003; 31:521-527 (Pubitemid 36793959)
23. Chen J, Ellison FM, Keyvanfar K, Omokaro SO, Desierto MJ, Eckhaus MA, et al. Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice. Exp Hematol 2008; 36:1236-1243
24. Akala OO, Park IK, Qian D, Pihalja M, Becker MW, Clarke MF. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature 2008; 453:228-232
25. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9:1428-1432
26. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423:302-305 (Pubitemid 40852701)
27. Yuan Y, Shen H, Franklin DS, Scadden DT, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 2004; 6:436-442
28. Yu H, Yuan Y, Shen H, Cheng T. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/ Waf1 in opposite manners. Blood 2006; 107:1200-1206 (Pubitemid 43156324)
29. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6:314-322 (Pubitemid 41724769)
30. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423:409-414 (Pubitemid 36626987)
31. Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci USA 2006; 103:14134-14139 (Pubitemid 44452992)
32. Domen J. The role of apoptosis in regulating hematopoiesis and hematopoietic stem cells. Immunol Res 2000;22:83-94. (Pubitemid 32382225)
33. Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K, et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005; 307:1101-1104 (Pubitemid 40262114)
34. Domen J, Gandy KL, Weissman IL. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 1998; 91:2272-2282 (Pubitemid 28155500)
35. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med 2000; 191:253-264 (Pubitemid 30060915)
36. Bender CF, Sikes ML, Sullivan R, Huye LE, Le Beau MM, Roth DB, et al. Cancer predisposition and hematopoietic failure in Rad50(S/S) mice. Genes Dev 22; 16:2237-2251
37. Morales M, Theunissen JW, Kim CF, Kitagawa R, Kastan MB, Petrini JH. The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor. Genes Dev 2005; 19:3043-3054 (Pubitemid 41798119)
38. Morales M, Liu Y, Laiakis EC, Morgan WF, Nimer SD, Petrini JH. DNA damage signaling in hematopoietic cells: a role for Mre11 complex repair of topoisomerase lesions. Cancer Res 2008; 68:2186-2193
39. Lotem J, Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 1993; 82:1092-1096 (Pubitemid 23253980)
40. Wlodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J, et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 1998; 91:2998-3006. (Pubitemid 28227552)
41. Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 2002; 99:16220-16225 (Pubitemid 35462776)
42. Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 2008; 22:986-991 (Pubitemid 351544237)
43. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003; 3:179-192
44. Pellagatti A, Hellström-Lindberg E, Giagounidis A, Perry J, Malcovati L, Della Porta MG, et al. Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol 2008; 142:57-64. (Pubitemid 351783162)
45. Danilova N, Sakamoto KM, Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008; 112:5228-5237
46. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ, et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008; 40:963-970
47. Gazda HT, Sieff CA. Recent insights into the pathogenesis of Diamond-Blackfan anaemia. Br J Haematol 2006; 135:149-157
48. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008; 451:335-339
49. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007; 8:703-713
50. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008; 132:681-696 (Pubitemid 351253688)
51. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725-729 (Pubitemid 46889729)
52. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443:421-426 (Pubitemid 44477274)
53. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415:45-53. (Pubitemid 34062443)
54. Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA, et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 2007; 109:1736-1742 (Pubitemid 46239609)
55. García-Cao I, García-Cao M, Tomás-Loba A, Martín-Caballero J, Flores JM, Klatt P, et al. Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep 2006; 7:546-552 (Pubitemid 43904873)
56. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804-1808 (Pubitemid 30143963)
57. van Os R, Kamminga LM, Ausema A, Bystrykh LV, Draijer DP, van Pelt K, et al. A Limited role for p21Cip1/ Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells 2007; 25:836-843 (Pubitemid 46572579)
58. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, et al. Cell cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009; 457:51-56
59. Peterson LF, Yan M, Zhang DE. The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO. Blood 2007; 109:4392-4398 (Pubitemid 46743408)
60. Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007; 39:99-105. (Pubitemid 46026508)
61. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, et al. Gfi-1 restricts proliferation and preserves functional integrity of hematopoietic stem cells. Nature 2004; 431:1002-1007 (Pubitemid 39434423)
62. Zeng H, Yücel R, Kosan C, Klein-Hitpass L, Möröy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 2004; 23:4116-4125 (Pubitemid 39472432)
63. Jay P, Rougeulle C, Massacrier A, Moncla A, Mattei MG, Malzac P, et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader- Willi syndrome chromosomal region. Nat Genet 1997; 17:357-361 (Pubitemid 27476006)
64. Davies HD, Leusink GL, McConnell A, Deyell M, Cassidy SB, Fick GH, et al. Myeloid leukemia in Prader- Willi syndrome. J Pediatr 2003; 142:174-178 (Pubitemid 36232908)
65. Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM. A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc Natl Acad Sci USA 2003; 100:10008-10013 (Pubitemid 37087059)
66. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999; 274:16142-16248 (Pubitemid 129526374)
67. Taniura H, Kobayashi M, Yoshikawa K. Functional domains of necdin for protein-protein interaction, nuclear matrix targeting and cell growth suppression. J Cell Biochem 2005; 94:804-815 (Pubitemid 41420277)
68. Gérard M, Hernandez L, Wevrick R, Stewart CL. Disruption of the mouse necdin gene results in early post-natal lethality. Nat Genet 1999; 23:199-202. (Pubitemid 29455393)
69. Inoue A, Seidel MG, Wu W, Kamizono S, Ferrando AA, Bronson RT, et al. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2002; 2:279-288 (Pubitemid 41043962)
70. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123:641-653 (Pubitemid 41613746)
71. Komarova NL, Wodarz D. Effect of cellular quiescence on the success of targeted CML therapy. PLos ONE 2007; 2:990.
72. Holtz M, Forman SJ, Bhatia R. Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment. Cancer Res 2007; 67:1113-1120 (Pubitemid 46270768)
73. Jordan CT, Guzman ML. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene 2004; 23:7178-7187